English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
U.S. Food And Drug Administration (fda)
Robert Hadley
| Jun 28, 2017
Pfizer a step closer to making $17B gamble on biosimilars pay off
Michael McGrady
| Jun 22, 2017
FDA chief wants to speed up approvals for digital health tech
Carol Ostrow
| Jun 19, 2017
UF study shows selexipag provides potential post-stroke protections
Michael McGrady
| Jun 15, 2017
Drug user fee reauthorization may spark innovation
Nicholas Gueguen
| Jun 15, 2017
Amgen says cholesterol-lowering drug Repatha may also reduce cardiovascular risks
Michael McGrady
| Jun 7, 2017
Federal agencies weigh in on Zika outbreak response
Robert Hadley
| Jun 2, 2017
FDA approves higher once-a-day dose of Merck’s Isentress HIV drug
Robert Hadley
| May 31, 2017
FDA greenlights review of Bristol-Myers Squibb’s Opdivo for liver cancer
Trending
+
Marketing
Patient Daily
| Sep 17, 2025
Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+
Regulatory
Patient Daily
| Sep 17, 2025
PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+
Pharmaceuticals
Patient Daily
| Sep 23, 2025
Wall Street Journal editorial board alleges hospitals misuse 340B program
Patient Daily
| Sep 19, 2025
ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’
« First
«
1
2
3
4
5
6
…
»
Last »